Cincinnati Children’s Hospital Medical Center has landed a five-year grant worth up to $17.25 million, securing its spot as one of the first U.S. sites in a new international autism research network. The money will back a long-term study that tracks both developmental and biological data, with the goal of speeding future clinical trials and matching participants with more targeted therapies. Local researchers say Wave 1 of the network is expected to launch rolling recruitment by the end of 2026.
In a press release via PR Newswire, Cincinnati Children’s said the award comes from Aligning Research to Impact Autism (ARIA) and will fund the hospital’s role in the Innovative Medicine and Precision Approaches to Clinical Trials (IMPACT) Network. “This is a monumental step for autism research,” said Craig Erickson, MD, who will serve as principal investigator for the local site. According to the release, study visits will include research electroencephalography (EEG), blood sampling for genetic and other testing, and repeated developmental assessments to build a detailed picture of each participant’s biology and behavior.
What the IMPACT Network Will Do
The ARIA-backed IMPACT Network is designed to standardize data collection, uncover biomarkers, and boost trial readiness across all participating centers. As detailed by Aligning Research to Impact Autism, Wave 1 sites, including Cincinnati Children’s as IMPACT Ohio, are expected to start recruiting participants on a rolling basis by the end of 2026. Central coordinating hubs will oversee common data standards and a shared biobank so that results from different hospitals can be pooled for more powerful studies.
How Local Families Can Connect
Cincinnati Children’s says the study will intentionally include individuals who have been underrepresented in clinical research and that visits will be adapted to each participant’s needs. Families who want to learn more or pre-register can visit the hospital’s SPARK study page or contact the research team at [email protected] or 513-318-7845, according to Cincinnati Children’s. The enrollment process may involve questionnaires, saliva or blood collection, EEG testing, and repeat visits over time.
Why It Matters Here
The award builds on what local leaders describe as a strong research ecosystem in Cincinnati. The University of Cincinnati and Cincinnati Children’s have been expanding translational infrastructure that supports multi-site trials and large-scale data sharing. As the University of Cincinnati notes, the region’s Center for Clinical & Translational Science & Training helps provide the backbone needed to move discoveries into clinical testing. That capacity could help turn the IMPACT Network’s data into clinical trials that reach Cincinnati children sooner.
Local coverage of the award is already underway, and The Business Journals reports that patient enrollment is projected to begin by the end of the year. Researchers say the long-term goal is to push autism care toward more precise and equitable treatments for people across the spectrum, with Cincinnati families among the first to see the benefits.
